Joachim Andrassy

Summary

Affiliation: University of Munich
Country: Germany

Publications

  1. doi request reprint Is cytomegalovirus prophylaxis dispensable in patients receiving an mTOR inhibitor-based immunosuppression? a systematic review and meta-analysis
    Joachim Andrassy
    Department of Surgery, University Hospital Grosshadern, Ludwig Maximilian s University, Munich Germany
    Transplantation 94:1208-17. 2012
  2. doi request reprint Endovascular versus open treatment of degenerative aneurysms of the descending thoracic aorta: a single center experience
    Joachim Andrassy
    Department of Surgery, University Hospital Grosshadern, Ludwig Maximilian s University, Munich, Germany
    Vascular 19:8-14. 2011
  3. doi request reprint Early conversion to a sirolimus-based, calcineurin-inhibitor-free immunosuppression in the SMART trial: observational results at 24 and 36months after transplantation
    Markus Guba
    Department of Surgery, Munich University Hospital, Campus Grosshadern, Munich, Germany
    Transpl Int 25:416-23. 2012
  4. ncbi request reprint Stent versus open surgery for acute and chronic traumatic injury of the thoracic aorta: a single-center experience
    Joachim Andrassy
    Department of Surgery, Klinikum Grosshadern, Ludwig Maximilians University, Munich, Germany
    J Trauma 60:765-71; discussion 771-2. 2006
  5. ncbi request reprint Immediate endovascular treatment of an aortoiliac aneurysm ruptured into the inferior vena cava
    Reinhard Kopp
    Department of Surgery, Klinikum Grosshadern, University of Munich, Munich, Germany
    Ann Vasc Surg 20:525-8. 2006
  6. doi request reprint Late reuse of liver allografts from brain-dead graft recipients: the Munich experience and a review of the literature
    Markus Rentsch
    Department of Surgery, University Hospital of Tubingen, Tubingen, Germany
    Liver Transpl 16:701-4. 2010
  7. ncbi request reprint mTOR inhibition and its effect on cancer in transplantation
    Joachim Andrassy
    Department of Surgery, Klinikum Grosshadern, Ludwig Maximilians University, Munich, Germany
    Transplantation 80:S171-4. 2005
  8. doi request reprint Impact of surgical training and surgeon's experience on early outcome in kidney transplantation
    Michael Thomas
    Department of Surgery, University of Munich, Großhadern, Munich, Germany
    Langenbecks Arch Surg 398:581-5. 2013
  9. pmc Shedding light on the elusive role of endothelial cells in cytomegalovirus dissemination
    Torsten Sacher
    Max von Pettenkofer Institute, Ludwig Maximilians University, Munich, Germany
    PLoS Pathog 7:e1002366. 2011
  10. doi request reprint Renal function, efficacy, and safety of sirolimus and mycophenolate mofetil after short-term calcineurin inhibitor-based quadruple therapy in de novo renal transplant patients: one-year analysis of a randomized multicenter trial
    Markus Guba
    Department of Surgery, Munich University Hospital, Campus Grosshadern, Munich, Germany
    Transplantation 90:175-83. 2010

Collaborators

Detail Information

Publications14

  1. doi request reprint Is cytomegalovirus prophylaxis dispensable in patients receiving an mTOR inhibitor-based immunosuppression? a systematic review and meta-analysis
    Joachim Andrassy
    Department of Surgery, University Hospital Grosshadern, Ludwig Maximilian s University, Munich Germany
    Transplantation 94:1208-17. 2012
    ..Here, we present a meta-analysis of clinical trials after solid organ transplantation and describe potential mechanisms involved in the anti-CMV effect of mTOR-inhibitors...
  2. doi request reprint Endovascular versus open treatment of degenerative aneurysms of the descending thoracic aorta: a single center experience
    Joachim Andrassy
    Department of Surgery, University Hospital Grosshadern, Ludwig Maximilian s University, Munich, Germany
    Vascular 19:8-14. 2011
    ..05) and in particular for the symptomatic patients (P = 0.003). In conclusion, endovascular treatment for patients with degenerative thoracic aortic aneurysms has significant advantages over open surgery...
  3. doi request reprint Early conversion to a sirolimus-based, calcineurin-inhibitor-free immunosuppression in the SMART trial: observational results at 24 and 36months after transplantation
    Markus Guba
    Department of Surgery, Munich University Hospital, Campus Grosshadern, Munich, Germany
    Transpl Int 25:416-23. 2012
    ..Patient selection will be key to derive long-term benefit and avoid treatment failure using this mTOR-inhibitor-based immunosuppressive regimen...
  4. ncbi request reprint Stent versus open surgery for acute and chronic traumatic injury of the thoracic aorta: a single-center experience
    Joachim Andrassy
    Department of Surgery, Klinikum Grosshadern, Ludwig Maximilians University, Munich, Germany
    J Trauma 60:765-71; discussion 771-2. 2006
    ..Traumatic injuries of the thoracic aorta have a high morbidity and mortality. Treatment options include either open surgery or endovascular stent graft implantation...
  5. ncbi request reprint Immediate endovascular treatment of an aortoiliac aneurysm ruptured into the inferior vena cava
    Reinhard Kopp
    Department of Surgery, Klinikum Grosshadern, University of Munich, Munich, Germany
    Ann Vasc Surg 20:525-8. 2006
    ..Endovascular exclusion of ruptured abdominal aneurysms seems to be a valuable treatment option for selected patients even with complicated vascular conditions like an aortocaval fistula...
  6. doi request reprint Late reuse of liver allografts from brain-dead graft recipients: the Munich experience and a review of the literature
    Markus Rentsch
    Department of Surgery, University Hospital of Tubingen, Tubingen, Germany
    Liver Transpl 16:701-4. 2010
    ..Here we report the case of a 43-year-old female donor who had received a liver graft for complications of Budd-Chiari syndrome 5 years before becoming an organ donor herself after cerebral infarction with consecutive brain death...
  7. ncbi request reprint mTOR inhibition and its effect on cancer in transplantation
    Joachim Andrassy
    Department of Surgery, Klinikum Grosshadern, Ludwig Maximilians University, Munich, Germany
    Transplantation 80:S171-4. 2005
    ..Here, we have reviewed the current literature trying to clarify if mTOR-inhibition brings advantages for the transplanted patients suffering from tumors...
  8. doi request reprint Impact of surgical training and surgeon's experience on early outcome in kidney transplantation
    Michael Thomas
    Department of Surgery, University of Munich, Großhadern, Munich, Germany
    Langenbecks Arch Surg 398:581-5. 2013
    ..The purpose of this study was to assess the impact of surgical training and surgeon's experience on surgical quality and early outcome parameters...
  9. pmc Shedding light on the elusive role of endothelial cells in cytomegalovirus dissemination
    Torsten Sacher
    Max von Pettenkofer Institute, Ludwig Maximilians University, Munich, Germany
    PLoS Pathog 7:e1002366. 2011
    ..These data contradict any privileged role of EC in CMV dissemination and challenge an indiscriminate applicability of the primary and secondary viremia concept of virus dissemination...
  10. doi request reprint Renal function, efficacy, and safety of sirolimus and mycophenolate mofetil after short-term calcineurin inhibitor-based quadruple therapy in de novo renal transplant patients: one-year analysis of a randomized multicenter trial
    Markus Guba
    Department of Surgery, Munich University Hospital, Campus Grosshadern, Munich, Germany
    Transplantation 90:175-83. 2010
    ..De novo sirolimus in calcineurin inhibitor-free regimens, although potentially useful to improve early renal function, are complicated by various drug-related side effects...
  11. ncbi request reprint Paclitaxel saves rat heart allografts from rejection by inhibition of the primed anti-donor humoral and cellular immune response: implications for transplant patients with cancer
    Stefan Tange
    Department of Surgery, University of Regensburg, Franz Josef Strauss Allee 11, 93053, Regensburg, Germany
    Transpl Int 16:471-5. 2003
    ....
  12. ncbi request reprint Rapamycin protects allografts from rejection while simultaneously attacking tumors in immunosuppressed mice
    Gudrun E Koehl
    Department of Surgery, The University of Regensburg, Regensburg, Germany
    Transplantation 77:1319-26. 2004
    ..Notably, CsA protects allografts from rejection, but cancer progression is promoted in transplant recipients...
  13. ncbi request reprint Use of an adenoviral vector to express soluble donor-major histocompatibility complex molecules capable of suppressing the immune response in rat transplant recipients
    Christian Graeb
    Department of Surgery, University of Regensburg, Franz Josef Strauss Allee 11, 93053 Regensburg, Germany
    Hum Immunol 63:844-52. 2002
    ....
  14. ncbi request reprint The antineoplastic drug Paclitaxel has immunosuppressive properties that can effectively promote allograft survival in a rat heart transplant model
    Stefan Tange
    University of Regensburg, Department of Surgery, Franz Josef Strauss Allee 11, 93053 Regensburg, Germany
    Transplantation 73:216-23. 2002
    ..Therefore, drugs with both immunosuppressive and antineoplastic activity are needed. We show that the anticancer agent paclitaxel may fulfill these diverse expectations...